- Home
- SRPT vs ZGN Comparison
SRPT vs ZGN Comparison
Compare SRPT & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | ZGN |
|---|---|---|
| Founded | 1980 | 1910 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SRPT | ZGN |
|---|---|---|
| Price | $21.06 | $12.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 4 |
| Target Price | ★ $25.85 | $11.28 |
| AVG Volume (30 Days) | ★ 2.3M | 626.4K |
| Earning Date | 05-06-2026 | 03-20-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | $5.17 |
| Revenue Next Year | N/A | $7.89 |
| P/E Ratio | ★ N/A | $25.94 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $7.61 |
| 52 Week High | $64.80 | $12.40 |
Technical Indicators
Market Signals| Indicator | SRPT | ZGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 63.21 |
| Support Level | $20.61 | $10.10 |
| Resistance Level | $22.69 | $12.40 |
| Average True Range (ATR) | 0.90 | 0.35 |
| MACD | -0.18 | -0.02 |
| Stochastic Oscillator | 65.94 | 84.43 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.